Comparative pharmacokinetics, efficacy, and safety of bevacizumab biosimilar to reference bevacizumab in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative pharmacokinetics, efficacy, and safety of bevacizumab biosimilar to reference bevacizumab in patients with metastatic colorectal cancer

Published:2017 Issue:3 Volume:54 Page:535
ISSN:0019-509X
Container-title:Indian Journal of Cancer
language:en
Short-container-title:Indian J Cancer

Author:

Apsangikar PrasadDattatray,Chaudhry SunilRamdev,Naik ManojMurlidhar,Deoghare ShashankBabarao,Joseph Jamila

Publisher

Medknow

Subject

Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of bevacizumab biosimilar on wound healing complications in patients with colorectal cancer undergoing endoscopic mucosal resection: A systematic review and meta‐analysis in anorectal medicine;International Wound Journal;2024-01

2. Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer;BioDrugs;2023-09-25

3. Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis;BioDrugs;2023-02-02

4. Characteristics of Clinical Trials Evaluating Biosimilars in the Treatment of Cancer;JAMA Oncology;2022-04-01

5. Real-world usage of bevacizumab-bvzr biosimilar in US oncology practice;The American Journal of Managed Care;2022-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP